Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Improving predictability of clinical trial outcomes

Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada
Improving predictability of clinical trial outcomes ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )
18 Jul 2013

Development of clinical decision support tools for physicians and patients

Dr Amy Abernethy – Duke University Medical Center, Durham, USA
Development of clinical decision support tools for physicians and patients ( Dr Amy Abernethy – Duke University Medical Center, Durham, USA )
18 Jul 2013

Identifying and applying molecular subgrouping in colorectal cancer

Dr Sabine Tejpar - University of Leuven, Leuven, Belgium
Identifying and applying molecular subgrouping in colorectal cancer ( Dr Sabine Tejpar - University of Leuven, Leuven, Belgium )
18 Jul 2013

Treatment of melanoma in Latin America

Dr Alessandro Testori - European Institute of Oncology, Milan, Italy
Treatment of melanoma in Latin America ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )
9 Jul 2013

Highlights from EHA 2013

Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands
Highlights from EHA 2013 ( Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
19 Jun 2013

Challenges facing haematologists treating acute myeloid leukaemia

Dr Dalia Mahmoud - Celgene Corporation, Summit, USA
Challenges facing haematologists treating acute myeloid leukaemia ( Dr Dalia Mahmoud - Celgene Corporation, Summit, USA )
19 Jun 2013

JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms

Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA
JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms ( Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA )
19 Jun 2013

Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms

Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA
Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms ( Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA )
18 Jun 2013

Vemurafenib and ipilimumab for metastatic melanoma

Dr Caroline Robert - Institute Gustave Roussy, Paris, France
Vemurafenib and ipilimumab for metastatic melanoma ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France )
14 Jun 2013

Monoclonal antibodies and targeting them against cancer cells in lymphoma

Prof Ronald Levy - Stanford University, USA
Monoclonal antibodies and targeting them against cancer cells in lymphoma ( Prof Ronald Levy - Stanford University, USA )
14 Jun 2013

Neo-angiogenesis and pathological angiogenesis in targeted molecules

Dr Wolfgang Wick - University of Heidelberg, Germany
Neo-angiogenesis and pathological angiogenesis in targeted molecules ( Dr Wolfgang Wick - University of Heidelberg, Germany )
14 Jun 2013

Role of microenvironment and stroma in cancer therapy

Dr Stephen Ansell - Mayo Clinic, Rochester, USA
Role of microenvironment and stroma in cancer therapy ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )
7 Jun 2013